Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-628-3 | CAS number: 1263184-87-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 Jul 2014 to 29 Jul 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP compliant, guideline study, available as unpublished report, no restrictions, fully adequate for assessment.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Version / remarks:
- Adopted: 7 September 2009
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1300 (Acute inhalation toxicity)
- Version / remarks:
- 1998
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.2 (Acute Toxicity (Inhalation))
- Version / remarks:
- 2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- traditional method
- Limit test:
- yes
Test material
- Reference substance name:
- rac-(1R,4S,4aR,8R,8aS)-9-(dichloromethylidene)-8-hydroxyoctahydro-1,4-methanonaphthalen-5(1H)-one
- EC Number:
- 941-628-3
- Cas Number:
- 1263184-87-7
- Molecular formula:
- C12H14Cl2O2
- IUPAC Name:
- rac-(1R,4S,4aR,8R,8aS)-9-(dichloromethylidene)-8-hydroxyoctahydro-1,4-methanonaphthalen-5(1H)-one
- Test material form:
- solid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- CRL
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 11-12 weeks
- Weight at study initiation: 401-535 g (males); 246-312 g (females)
- Fasting period before study: No
- Housing: 5 per sex in Type III solid floor cages with stainless steel mesh lids. Rodents were housed with deep wood sawdust bedding to allow digging and other normal rodent activities. Lignocel Bedding for Laboratory Animals was available to animals during the study.
- Diet: Autoclavable Complete Feed for Rats and Mice – Breeding and Maintenance, ad libitum, except during exposure.
- Water: Tap water ad libitum, except during exposure.
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.2-26.5
- Humidity (%): 30-72
- Air changes (per hr): 15-20
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES:
15 Jul 2014 to 29 Jul 2014
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- air
- Mass median aerodynamic diameter (MMAD):
- 3.01 µm
- Geometric standard deviation (GSD):
- 2.27
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Rodent Exposure System
- Exposure chamber volume: 3.85 L (inner plenum)
- Method of holding animals in test chamber: The animals were held in polycarbonate restraint tubes located around the chamber which allowed only the animal’s nares to enter the exposure port.
- Rate of air flow in (inner plenum): 15.0 L/min
- Rate of air flow out (inner plenum): 29.9 L/min
- System of generating particulates/aerosols: The test item was aerosolised using two Dust Feed Systems located at the top of the exposure chamber. Compressed air was supplied by means of an oil-free compressor and passed through a suitable filter system prior to introduction to the dust generator.
- Method of particle size determination: The particle size of the test atmosphere was determined three times during the exposure period using a 7-stage impactor of Mercer style.
- Temperature, humidity, oxygen concentration in air chamber: 23.6°C, humidity not recorded, oxygen concentration 20.6%.
TEST ATMOSPHERE
- Brief description of analytical method used: A known volume of test atmosphere was passed through weighed GF10 glass fibre filters. The difference in the pre- and post-sampling weights, divided by the volume of atmosphere sampled, was equal to the actual achieved test atmosphere concentration.
The nominal concentration was calculated by dividing the mass of test material disseminated into the chamber by the total volume of air that went through the chamber during the same period.
- Samples taken from breathing zone: Yes
TEST ATMOSPHERE
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): 3.01 µm / 2.27 - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- Target concentration 5 mg/L. Actual avarage concentration 5.05 ± 0.12 mg/L.
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observed once per hour during exposure, as soon as possible following removal from restrains at the end of exposure, 1 hour after exposure and twice daily for 14 days thereafter. Body weights were recorded prior to treatment on the day of exposure (Day 0) and on Days 1, 3, 7 and 14.
- Necropsy of survivors performed: Yes. After examination of the external appearance, the thoracic and abdominal cavities were opened and the appearance of the tissues and organs were observed. Any gross macroscopic changes were recorded. Special attention was given to the respiratory tract for macroscopic signs of irritancy or local toxicity. - Statistics:
- Not applicable (limit test, no mortalities).
Results and discussion
- Preliminary study:
- Sighting Exposure:
The mean achieved atmosphere concentration was 5.03 mg/L. The MMAD (Mean Mass Aerodynamic Diameter) was 3.01 μm ± 2.31 (GSD [Geometric Standard Deviation]). There was no mortality.
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.05 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- There was no mortality.
- Clinical signs:
- other: Wet fur and/or fur staining were recorded in animals on the day of exposure and in some occasions on the day following exposure. These observations were considered to be related to the restraint and exposure procedures and, in isolation, were considered n
- Body weight:
- Normal body weight gain was noted for all exposed animals during the observation period, with the exception of one female where slight body weight loss was observed during period Day 1-3.
- Gross pathology:
- No treatment-related findings.
Any other information on results incl. tables
Table 1: Summary of acute study test atmosphere characteristics
Achieved concentration |
5.05 ± 0.12 mg/L (n=17) |
Nominal concentration |
9.37.mg/L |
Particle size MMAD; GSD |
3.01 µm; 2.27 (n=3) |
Inhalable fraction (% <4 µm) |
63.6 |
|
Cumulative Mass (%) |
Particles<0.55µm |
2.95 (n=3) |
Particles0.55-0.96µm |
8.06 (n=3) |
Particles0.96-1.55µm |
15.70 (n=3) |
Particles1.55-2.11µm |
26.29 (n=3) |
Particles2.11-3.56µm |
62.28 (n=3) |
Particles3.56–6.66µm |
85.83 (n=3) |
Particles6.66-10.55µm |
93.84 (n=3) |
Particles>10.55µm |
100.00 |
Flow rate in (Inner plenum) (whole system) |
15.0 L/min |
Flow rate out (outer cylinder) |
29.9 L/min |
Theoretical chamber equilibrium time (T99) |
1 minute |
Actual equilibrium time allowed |
11 minutes |
Temperature |
23.6°C (maximum/minimum 22.5/24.0°C) |
Humidity |
Not measured |
Oxygen content |
20.6% (maximum/minimum 20.3/20.8%) |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the experimental conditions of this study, no deaths occurred in a group of 10 rats exposed to a mean achieved concentration of 5.05 mg/L for 4 hours. The acute inhalation median lethal concentration (LC50) in CRL: (WI) Wistar strain rats is, therefore, considered to be greater than 5.05 mg/L.
- Executive summary:
In this GLP compliant, OECD 403 acute inhalation toxicity study, 5 male and 5 female CRL: (WI) Wistar strain rats, were exposed to a mean achieved concentration of 5.05 mg/L test substance for 4 hours using a nose-only exposure system, followed by a 14 day observation period. The day of exposure was designated Day 0. Aerosol concentrations were measured gravimetrically. The particle size distribution of the test aerosol was determined regularly during the exposure period. Clinical observations and body weights were recorded throughout the study and at the end of the scheduled period the animals were euthanised and subjected to a gross examination post mortem.
The mean achieved atmosphere concentration was 5.05 mg/L. The MMAD (Mean Mass Aerodynamic Diameter) was 3.01 μm ± 2.27 (GSD [Geometric Standard Deviation]). There was no mortality. Wet fur and/or fur staining were recorded in animals on the day of exposure and in some occasions on the day following exposure. These observations were considered to be related to the restraint and exposure procedures and, in isolation, were considered not to be of toxicological relevance. Only slight to moderate laboured respiration was noted for the exposed animals on the day of exposure. No clinical signs were noted from Day 1 until the end of the observation period. Normal body weight gain was noted for all exposed animals during the observation period, with the exception of one female where slight body weight loss was observed during period Day 1-3. There were no treatment-related changes at gross examination post mortem.
Under the experimental conditions of this study, no deaths occurred in a group of 10 rats exposed to a mean achieved concentration of 5.05 mg/L for 4 hours. The acute inhalation median lethal concentration (LC50) in CRL: (WI) Wistar strain rats is, therefore, considered to be greater than 5.05 mg/L.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.